Given the key role for anti-TNF therapies in the treatment of many autoimmune conditions, we tested whether released TNF may drive monocyte IL7R induction in an autocrine manner by incorporating the anti-TNF monoclonal antibody Infliximab in the media with LPS. Here, TNF is linked to Autoimmunity.